SecBot SecBot
COURT-RULING ·Filed Aug 19, 2026

COLL

COLLEGIUM PHARMACEUTICAL, INC
MIXED
Impact 5/10
Horizonmonths Processed2mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight ◆ Mixed

The dismissal of breach-of-contract claims removes the most direct liability theory, but the surviving unjust enrichment and Chapter 93A claims keep $14.3M in potential exposure alive. Monitor for summary judgment motions on the remaining claims and any settlement discussions, as the case now hinges on equitable rather than contractual theories.

DirectionMixed
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$27.54
T+0 close · Aug 20, 2026 · via day close
Latest settled
−8.06%
T+60 · $25.32
Vs SPY
−6.98%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 20 $27.54entry
  2. T+1 · 3mo ago −1.56%α −1.97% · $27.11
  3. T+5 · 3mo ago −3.99%α −5.11% · $26.44
  4. T+20 · 2mo ago −17.32%α −17.20% · $22.77
  5. T+60 · 4d ago −8.06%α −6.98% · $25.32
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Collegium Pharmaceutical won partial dismissal of Walgreens' breach-of-contract lawsuit in Massachusetts federal court. The court dismissed Walgreens' breach of contract and implied covenant claims (Counts I and II) with prejudice, finding no contractual relationship existed between the parties. However, Walgreens' unjust enrichment claim (Count IV) and Massachusetts Chapter 93A unfair/deceptive trade practices claim (Count III) survived the motion to dismiss, with Walgreens seeking $14.3 million in damages for allegedly delayed product returns. The case proceeds on these two claims, creating ongoing litigation risk but removing the most direct contractual liability exposure.

Court Ruling Details

Ruling Date
Aug 19, 2026
Court
United States District Court for the District of Massachusetts
Court Level
District
Judge
Brian E. Murphy
Case Type
contract
Ruling Type
motion to dismiss
Outcome
PARTIAL: mixed ruling, some claims won/lost
Damages Range
Walgreens pleaded $14,321,229.99 in damages
Precedent Risk
LOW
Market Cap Exposure
1.53%

Key Facts

  • Court dismissed breach of contract (Count I) and implied covenant (Count II) claims against Collegium, finding no enforceable contract existed between Walgreens and Collegium.
  • Walgreens' unjust enrichment claim (Count IV) survived, alleging Collegium retained $14,321,229.99 in value from products Walgreens could not return due to delayed Form 222 authorizations.
  • Walgreens' Chapter 93A unfair/deceptive trade practices claim (Count III) survived the motion to dismiss.
  • The case was originally filed in June 2025 in Illinois, dismissed for lack of personal jurisdiction in February 2026, and refiled in Massachusetts in March 2026.
  • Collegium's statute of limitations defense was not resolved at this stage, with the court noting factual questions remain about when the alleged misconduct occurred.

Financial Impact

Walgreens seeks $14.3 million in damages for allegedly unreturned product value; Collegium faces ongoing litigation costs and potential liability on two surviving claims

litigation_exposurelegal_expenses

Risk Factors

  • $14.3 million in potential damages on surviving unjust enrichment and Chapter 93A claims
  • Ongoing litigation costs and management distraction
  • Chapter 93A claim carries potential for treble damages and attorneys' fees if Collegium loses

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-f9fa049eaf-COLL

Track record

24 reports on COLL

Performance horizon

1 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +0.28% at T+1 after the Aug 13, 2026 report. 1 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $25.68 Now $25.43 −0.97% settles Nov 17
  2. Nov 10, 20266d ago SC 13G/A Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $24.47 to $24.81 Now $25.43 +3.92% ▲ +1.39% +0.07% vs SPY
  4. Nov 9, 20267d ago Institutional Cluster Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
  5. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  6. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $25.16 to $24.21 Now $25.43 +1.07% ▼ −3.78% −4.09% vs SPY
  7. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $23.80 to $23.68 Now $25.43 +6.85% ▼ −0.50% −0.03% vs SPY
  8. Oct 29, 202618d ago SC 13G/A Neutral 3/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
  9. Oct 29, 202618d ago Press Release Neutral 2/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
  10. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $23.50 to $22.96 Now $25.43 +8.21% ▼ −2.30% −1.78% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Aug 20, 2026